| Literature DB >> 28725687 |
Moran Gilat1, James M Shine1,2, Courtney C Walton1, Claire O'Callaghan1,3, Julie M Hall1,4, Simon J G Lewis1.
Abstract
BACKGROUND: Freezing of gait is a debilitating symptom affecting many patients with Parkinson's disease (PD), causing severe immobility and decreased quality of life. Turning is known to be the most common trigger for freezing and also causes the highest rates of falls. However, the pathophysiological basis for these effects is not well understood.Entities:
Year: 2015 PMID: 28725687 PMCID: PMC5516618 DOI: 10.1038/npjparkd.2015.20
Source DB: PubMed Journal: NPJ Parkinsons Dis ISSN: 2373-8057
Figure 1Representation of the virtual reality task showing a turn, a period of virtual reality walking and a WALK and STOP cue. WALK, walking.
Brain areas with significantly different BOLD responses in the second level using an independent t-test design for the contrast turning>walking in the virtual reality task, showing the PD+FOG>PD−NF peak voxel statistics
|
| x | y | z |
| T- | Z- | P- |
|---|---|---|---|---|---|---|---|
| L—SMA—Premotor | −21 | −7 | 64 | 59 | −4.17 | 3.54 | <0.001 |
| L—Parietal superior | −30 | −46 | 58 | 57 | −3.91 | 3.37 | <0.001 |
| L—Inferior frontal | −30 | 35 | 13 | 35 | 3.58 | 3.14 | <0.002 |
| R—Inferior frontal | 36 | 20 | 25 | 20 | 4.04 | 3.46 | <0.001 |
Abbreviations: BOLD, blood oxygen level-dependent; L—SMA, left supplementary motor area; PD+FOG, Parkinson’s disease patients with freezing of gait; PD−NF, Parkinson’s disease patients without freezing of gait; R, right.
k>20, P<0.005, uncorrected with coordinates in MNI space.
Demographic statistics and behavioral results
|
|
| |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
| T- | P- |
| Age | 67.4 | 6.2 | 64.8 | 4.1 | 1.15 | 0.262 |
| Disease duration | 116 | 63 | 92.4 | 28 | 1.09 | 0.285 |
| DDE | 776 | 321 | 785 | 296 | 0.07 | 0.945 |
| UPDRS-III | 37.2 | 12 | 30.1 | 11 | 1.53 | 0.139 |
| MMSE | 28.0 | 2.2 | 29.4 | 0.7 | 1.96 | 0.061 |
| MOCA | 25.6 | 3.2 | 28.3 | 2.3 | 2.36 | 0.027 |
| HADS (Anxiety) | 6.12 | 3.3 | 3.40 | 2.4 | 2.29 | 0.031 |
| HADS (Depression) | 5.59 | 2.6 | 1.40 | 1.7 | 4.53 | <0.01 |
| Median | Range | Median | Range | Z- | P- | |
| H&Y | 2.5 | 2.0–3.0 | 2.0 | 2.0–2.5 | −1.55 | 0.122 |
| FOG-Q3 | 3.10 | 2.0–4.0 | 0 | 0 | −4.14 | <0.01 |
| UPDRS 3.7a (Toe tap R) | 2.0 | 0–3.0 | 1.0 | 0–2.0 | −1.70 | 0.127 |
| UPDRS 3.7b (Toe tap L) | 2.0 | 0–3.0 | 1.0 | 0–2.0 | −1.13 | 0.286 |
| UPDRS 3.8a (Leg agility R) | 1.0 | 0–3.0 | 1.0 | 0–2.0 | −1.67 | 0.127 |
| UPDRS 3.8b (Leg agility L) | 1.0 | 0–3.0 | 1.0 | 0–2.0 | −1.33 | 0.223 |
| Virtual Reality task | Mean | s.d. | Mean | s.d. | T- | P- |
| Max SFSL turning | 1.14 | 0.09 | 1.07 | 0.10 | 2.33 | 0.028 |
| Max SFSL walking | 1.12 | 0.09 | 1.06 | 0.02 | 2.34 | 0.027 |
| CV turning | 16.5 | 5.84 | 9.60 | 3.9 | 3.31 | <0.01 |
| CV walking | 15.7 | 5.44 | 9.26 | 3.9 | 3.27 | <0.01 |
| Modal FSL | 0.56 | 0.11 | 0.62 | 0.10 | 1.39 | 0.172 |
Abbreviations: PD+FOG, Parkinson’s disease patients with freezing of gait; PD−NF, Parkinson’s disease patients without freezing of gait.
Independent sample t-test results presented unless otherwise indicated.
Demographics: Disease duration given in months, DDE, daily dopamine dose equivalence; FOG-Q3, question 3 of the freezing of gait questionnaire; HADS, hospital anxiety and depression scale; H&Y, Hoehn and Yahr; MMSE, Mini Mental State Examination; MOCA, Montreal Cognitive Assessment; UPDRS-III, motor section of the unified Parkinson’s disease rating scale without Q10 (gait) and Q11 (freezing); UPDRS 3.7 and 3.8, Average scores on Q3.7a and Q3.7b and 3.8a and 3.8b of the UPDRS (Left and right toe tapping and leg agility, respectively). Virtual Reality task: CV, coefficient of variation; Max SFSL, maximum scaled footstep latency as scaled to the modal FSL; Modal FSL, modal footstep latency. All analyses were two-tailed with an alpha of 0.05.
Mann–Whitney U-test used.
Figure 2Within-group whole brain results for periods of walking (WALK) and turning (TURN) in the virtual reality task. A, anterior, L, left; P, posterior, R, right; k>20 and P<0.005.
Figure 3Within-group whole brain results for the contrast turning>walking in the virtual reality task. A, anterior, L, left; P, posterior, R, right; k>20 and P<0.005.
Figure 4Results of the whole brain second level group effect for turning>walking in the virtual reality task. (a) Screenshots from the whole brain second level independent t-test for the turning >walking contrast showing PD+FOG>PD−NF results (P=Posterior, A=Anterior, k>20,P<0.005, uncorrected, see Table 2), while using MOCA and HADS scores as covariates and. (b) The average beta intensities of the peak voxel 8 mm spherical ROI’s for the turning >walking contrast in the virtual reality task for both Parkinson’s disease patients with freezing of gait (FOG) and without freezing of gait (NF). HADS, Hospital Anxiety and Depression Scale; MOCA, Montreal Cognitive Assessment; PD+FOG, Parkinson’s disease patients with freezing of gait; PD−NF, Parkinson’s disease patients without freezing of gait; ROI, regions of interest.
Figure 5Representation of the task based functional connectivity results. Figure shows the comparison between periods of turning and periods of walking in the virtual reality task within the Parkinson’s disease patients with freezing of gait group. CLR, cerebellar locomotor region; GPi, globus pallidus internus; MLR, mesencephalic locomotor region; STN, subthalamic nucleus.